¼¼°è ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº°: »ê¾÷ ºÐ¼® : ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2023³â-2030³â)
Patient-Controlled Analgesic Pumps Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1419051
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 323 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,526,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,476,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,869,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 4¾ï 2,020¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2023³âºÎÅÍ 2030³â±îÁö º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6.1%·Î È®´ëµÉ Àü¸ÁÀÔ´Ï´Ù.

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå - ½ÃÀå ¿ªÇÐ

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁÀÇ ±â¼ú Áøº¸°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁø

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁÀÇ ±â¼úÀû Áøº¸´Â ¸¸¼º ÁúȯÀÇ »ó´çÇÑ Áõ°¡¿¡ ÈûÀÔ¾î PCA ÆßÇÁ ½ÃÀå¿¡ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ Á¤ºñµÈ ¹Ì°³Ã´ ½ÅÈï ½ÃÀå, ¾Ï¸ä °Ç°­ °ü¸® ¿ä±¸ Áõ°¡, ¸¸¼º Áúȯ À¯º´·ü Áõ°¡, Áøº¸µÈ ÁøÅë ÆßÇÁ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ¶Ù¾î³­ ÇコÄÉ¾î ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí, ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ, ÀÇ·á Åõ¾î¸®Áò ½ÃÀå °³Ã´ µî¿¡ ÃßÁøµÈ ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ ÇコÄÉ¾î »ê¾÷ÀÇ Áøº¸µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÅëÁõ °ü¸®¸¦ ÇÊ¿ä·Î ÇÏ´Â ¿Ü°ú ¼ö¼ú Áõ°¡·Î ÅëÁõ »ç·ÊÀÇ ±ÞÁõÀº Àú·ÅÇÑ PCA ÆßÇÁÀÇ Çʿ伺À» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸ÀÇ ±ÞÁõÀº PCA ÆßÇÁ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ̵Ǿú½À´Ï´Ù. °í·ÉÈ­ »çȸ´Â ¸é¿ª·ÂÀÇ ÀúÇÏ¿Í ÅðÇà °úÁ¤¿¡ ÀÇÇÑ Áúº´ °¨¼ö¼º Áõ°¡¸¦ ³ªÅ¸³À´Ï´Ù. ¼¼°è ³ëÀÎ Àα¸´Â Å©°Ô È®´ëµÇ°í ÀÖÀ¸¸ç ½ÉÇ÷°ü Áúȯ, ³úÁ¹Áß, ´ç´¢º´, À§ ¹®Á¦, Àå Áúȯ µî ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ Ãë¾à¼ºÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ¼¼°è ½ÃÀåÀº Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀåÀº Á¦Ç° À¯Çü¿¡ µû¶ó µÎ °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù: ÀüÀÚ½Ä ¹× ±â°è½Ä. ÀüÀÚ ÆßÇÁ Ä«Å×°í¸®´Â ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå¿¡¼­ Áö¹èÀû ÀÎ ºÎ¹®À¸·Î ºÎ»óÇÏ¿© 2022³â »ó´çÇÑ ¼öÀÍ °øÀ¯¸¦ º¸ÀåÇÕ´Ï´Ù. ÀÌ ÀüÀÚ½Ä ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ´Â °í¼º´É ´ÜÀÏ Ä¨ ¸¶ÀÌÅ©·Î ÄÄÇ»ÅÍ¿Í Á¦¾î ȸ·Î¸¦ »ç¿ëÇÏ¿© ÁÖÀÔ À¯·®À» È¿À²ÀûÀ¸·Î Á¶ÀýÇÕ´Ï´Ù. ƯÈ÷ Ãâ»ê ½Ã ȯÀÚ °ü¸® °æ¸· ¿Ü ÁøÅë°ú ¼ö¼ú ÈÄ ÅëÁõ °ü¸®¿¡ È¿°úÀûÀÌ°í ¾ÈÀüÇϱ⠶§¹®¿¡ ÀÌ ºÎ¹® ¼ö¿ä¸¦ Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí ÀÎÀ§Àû ¶Ç´Â Àåºñ °ü·Ã Åõ¿© ¿À·ù·Î ÀÎÇÑ ÀáÀçÀûÀÎ PCA Ä¡·á ¿À·ù´Â ºÐ¼® ±â°£ µ¿¾ÈÀÌ ºÐ¾ßÀÇ ¼ºÀå Àü¸ÁÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾ »ç¿ëÀÚ¿¡ ÀÇÇØ ¼¼ °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù: º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× ±âŸ. º´¿øÀº ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ ÃÖÁ¾ »ç¿ëÀÚ ±¸ºÐÀ¸·Î ºÎ»óÇÏ¿© 2022³â¿¡ Å« ¼öÀÍ Á¡À¯À²À» ¾ò¾ú½À´Ï´Ù. ȯÀÚ Á¦¾î ÁøÅë ¿ä¹ýÀº ƯÈ÷ ¼ö¼ú ÈÄ È¯ÀÚÀÇ ÅëÁõÀ» ¿ÏÈ­Çϱâ À§ÇØ º´¿ø ³»¿¡¼­ ³Î¸® »ç¿ëµË´Ï´Ù. º´¿ø ³»¿¡¼­ ½º¸¶Æ®ÇÏ°í °í±Þ ȯÀÚ ÀÚ°¡ Á¶Àý ÁøÅë ÆßÇÁÀÇ º¸±ÞÀº ƯÈ÷ ½ÅÈï±¹ÀÇ ½Å¼³ º´¿ø¿¡¼­ °í±Þ PCA ÆßÇÁ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ Àü¸ÁÀÔ´Ï´Ù.

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¢ Áö¿ªÀ¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Á¦°øÇÏ´Â ±¹°¡¿¡ ÀÇÇØ ´õ ³ª´¹´Ï´Ù.

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå - °æÀï ±¸µµ :

ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁÀÇ °æÀï ¿µ¿ª¿¡¼­ °¢ ȸ»ç´Â ±â¼ú Çõ½Å, »ç¿ëÀÚ Á᫐ ¼³°è, ¾ÈÀü °­È­¸¦ Áß½ÉÀ¸·Î Àü·«Àû Á¢±ÙÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¿¬±¸ ÀÌ´Ï¼ÅÆ¼ºê´Â PCA ÆßÇÁ ±â¼úÀÇ ¹ßÀüÀ» ÃËÁøÇÏ°í »ç¿ëÀÚ Ä£È­Àû ÀÎ ÀÎÅÍÆäÀ̽º, ¹«¼± ¿¬°áÀ» ÅëÇÑ ¿ø°Ý ¸ð´ÏÅ͸µ ¹× Á¤È®ÇÑ Åõ¿© ¸ÞÄ¿´ÏÁòÀ» ÅëÇÕÇÕ´Ï´Ù. ȯÀÚ ±³À°°ú ÀÇ·á Àü¹®°¡ÀÇ ±³À°À» Áß½ÃÇÔÀ¸·Î½á ¾ÈÀü ÇÁ·ÎÅäÄÝÀ» ÃßÁøÇϸ鼭 ÀûÀýÇÑ »ç¿ëÀ» º¸ÀåÇÕ´Ï´Ù. ÀÇ·á ±â°ü°úÀÇ Àü·«Àû Á¦ÈÞ´Â ½ÃÀå ħÅõ¿Í ä¿ëÀ» ÃËÁøÇÕ´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÁؼöÇÏ°í µ¥ÀÌÅÍ º¸¾ÈÀ» ¼±È£ÇÔÀ¸·Î½á ±â¾÷ÀÇ ÁöÀ§´Â ´õ¿í °ß°íÇÕ´Ï´Ù. °æÀï ±¸µµÀº PCA ÆßÇÁ ½ÃÀåÀÇ ±â¼ú Áøº¸, ¾ÈÀü ´ëÃ¥ ¹× È®Àå Àü·«ÀÇ Á¶È­·Î¿î È¥ÇÕ¿¡ ´Þ·Á ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ¾÷°è Á¶»ç

Á¦5Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå »óȲ

Á¦7Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå : Á¦Ç° À¯Çüº°

Á¦8Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå : ¿ëµµº°

Á¦9Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ ½ÃÀå : Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÚ°¡Á¶Àý ÁøÅë(PCA) ÆßÇÁ »ê¾÷

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Patient-Controlled Analgesic Pumps Market size was valued at USD 420.2 Million in 2022, expanding at a CAGR of 6.1% from 2023 to 2030.

Patient-controlled analgesic (PCA) pumps are healthcare devices empowering patients to self-administer pain relief medication within predetermined safety boundaries. Commonly utilized post-surgery, during labor, or in scenarios necessitating pain management, these pumps house medication reservoirs like morphine, hydromorphone, or fentanyl, connected to an IV line or catheter. Healthcare professionals program these pumps to dispense a specified medication dose upon patient activation. Patients trigger the pump by pressing a button within safety parameters, controlling dosage and intervals for pain relief. PCA pumps provide advantages such as enhanced pain control, reduced opioid consumption via self-regulation, and increased patient satisfaction by granting control over pain management. However, healthcare providers closely supervise PCA pump usage to prevent complications or overdose resulting from misuse or surpassing set limits.

Patient-Controlled Analgesic Pumps Market- Market Dynamics

Technological advancements in patient-controlled analgesia pumps to propel market demand

Technological advancements in patient-controlled analgesia pumps, propelled by a significant pool of chronic diseases, present an opportunity for the PCA pumps market. Market growth is anticipated due to untapped emerging markets with improved healthcare infrastructure, rising unmet healthcare needs, increased chronic disease prevalence, and higher demand for advanced analgesic pumps. Additionally, healthcare industry progression in emerging economies, fueled by augmented demand for superior healthcare services, government investments in healthcare infrastructure, and the development of medical tourism, contributes to market expansion. Moreover, the surge in pain cases from increased surgical procedures requiring pain management escalates the necessity for affordable PCA pumps. Additionally, the rapid rise in the aging population serves as a primary driver for the PCA pumps market. Aging populations exhibit heightened disease susceptibility due to decreased immunity and degenerative processes. The global geriatric demographic has expanded significantly and faces increased vulnerability to various disorders like cardiovascular diseases, strokes, diabetes, gastric issues, and intestinal illnesses.

Patient-Controlled Analgesic Pumps Market- Key Insights

Patient-Controlled Analgesic Pumps Market- Segmentation Analysis:

The Global Patient-Controlled Analgesic Pumps Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on product type: Electronic and Mechanical. The electronic pumps category emerged as the dominant sector in the patient-controlled analgesic pump market, securing a substantial revenue share in 2022. These electronically operated patient-controlled analgesic pumps utilize high-performance single-chip microcomputers and control circuits to efficiently regulate infusion flow rates. Particularly effective and safe for Patient-controlled Epidural Analgesia during childbirth and for managing postoperative pain, they significantly drive the segment's demand. Nevertheless, potential PCA treatment errors, stemming from human or equipment-related dosing errors, may impede the segment's growth prospects during the analysis timeframe.

The market is divided into three categories based on end user: Hospitals, Ambulatory surgical centers and others. Hospitals emerged as the dominant end-user segment in the patient-controlled analgesic pump market, capturing a significant revenue share in 2022. Patient-controlled analgesic therapy finds extensive utilization within hospital settings, notably reducing post-operative patient pain. The prevalence of smart and advanced patient-controlled analgesic pumps within hospitals, coupled with escalating demand for sophisticated PCA pumps in newly established hospitals, especially in developing nations, is poised to fuel market growth.

Patient-Controlled Analgesic Pumps Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Patient-Controlled Analgesic Pumps Market- Competitive Landscape:

In the competitive sphere of patient-controlled analgesic (PCA) pumps, companies adopt strategic approaches centered on innovation, user-centric design, and safety enhancements. Ongoing research initiatives drive the advancement of PCA pump technologies, integrating user-friendly interfaces, remote monitoring through wireless connectivity, and precise dosing mechanisms. Emphasizing patient education and healthcare professional training ensures appropriate usage while promoting safety protocols. Strategic alliances with healthcare institutions facilitate market penetration and adoption. Complying with stringent regulatory standards and prioritizing data security further fortify company standings. The competitive landscape hinges on a harmonious blend of technological progress, safety measures, and expansion strategies in the PCA pump market.

Recent Developments:

In August 2022, Baxter International Inc. disclosed the U.S. Food and Drug Administration (FDA) 510(k) approval for its Novum IQ infusion pump, featuring Dose IQ safety software and IQ Enterprise connectivity suite.

In March 2022, Shanghai MicroPort Lifesciences Co., Ltd. obtained marketing approval from the National Medical Products Administration (NMPA) of China for their AutoEx chemotherapy infusion pump.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET KEY PLAYERS

GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET, BY PRODUCT TYPE

GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET, BY APPLICATION

GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET, BY END USER

GLOBAL PATIENT-CONTROLLED ANALGESIC PUMPS MARKET, BY REGION

Table of Contents

1. Patient-Controlled Analgesic Pumps Market Overview

2. Executive Summary

3. Patient-Controlled Analgesic Pumps Key Market Trends

4. Patient-Controlled Analgesic Pumps Industry Study

5. Patient-Controlled Analgesic Pumps Market: COVID-19 Impact Analysis

6. Patient-Controlled Analgesic Pumps Market Landscape

7. Patient-Controlled Analgesic Pumps Market - By Product type

8. Patient-Controlled Analgesic Pumps Market - By Application

9. Patient-Controlled Analgesic Pumps Market - By End user

10. Patient-Controlled Analgesic Pumps Market- By Geography

11. Key Vendor Analysis- Patient-Controlled Analgesic Pumps Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â